Abstract
An estimated 8250 new cases of testicular cancer will be diagnosed in the United States in 2006, with germ cell tumors (GCTs) constituting 95% of the malignant tumors arising in the testes. Although GCTs are relatively uncommon tumors, they are the most common solid tumor in men between the ages of 15 and 34 years. The worldwide incidence of these tumors has more than doubled in the past 40 years. More than 90% of all patients diagnosed with GCTs are cured, including 70% to 80% of patients with advanced tumors who are treated with chemotherapy. Standard therapy has been established at essentially all stages of management and must be closely followed to ensure the potential for cure.
For the most recent version of the guidelines, please visit NCCN.org
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Diagnosis and Clinical Staging;A Guide to Management of Urological Cancers;2023
2. Histological Classification of Testicular Cancer;Urological Cancer Management;2015
3. Testicular Cancer;Clinical Uro-Andrology;2014-12-04
4. Beyond Stage I Germ Cell Tumors: Current Status Regarding Treatment and Long-Term Toxicities;American Society of Clinical Oncology Educational Book;2014-05
5. Neoplasms of the Testis;Campbell-Walsh Urology;2012